Blue Horseshoe Stocks: Week Kicks Off on High Note


Yesterday, despite the fact that the markets as a whole were on pace for the longest sustained backslide in more than half a decade, we still managed to see new highs in a few of the stocks we’ve been tracking.  We also observed solid intraday performances from a couple other plays that were on our morning watchlist, so we’ll begin today with a quick roundup of all these movers.

Dolat Ventures, Inc. DOLV

We signaled our interest in tracking DOLV in Thursday’s report, and at the time we’d witness the stock trading at a low of .0056.

Yesterday concluded with a new high, and the recording of three straight bullish sessions since then, with DOLV trading in an intraday range from .0125 to .019, for a gain of 52% It brings the updated figure on the three session swing we’ve seen so far to an impressive 239%


MyDx, Inc. MYDX

We circled back to MYDX, a stock we’ve tracked all the way from a February low of .001, last Wednesday, while it was trading as low as .0077. It too has put together a multi-day run leading to impressive new highs once again yesterday.

The stock saw a daily range of .017-.0226, which represents an increase of 32% on the day, 193% from last Wednesday’s low, and a ridiculous 2160% from our witnessed low in February!


U.S. Stem Cell, Inc. USRM

Here’s another stock whose low (.014) came during the month of February, following our report on the 27th. We’ve been all over it since then , and in two sustained bursts it has absolutely soared.

After reminding our readers of that fact in yesterday’s premarket report, USRM managed to hit yet another new high for us. It traded from .07-.112 for a daily boost of 60% and the new high recorded pushed our overall observed gain on this play in just one months time to an even 700%


Honorable Mentions

We placed a couple of plays in yesterday’s extended watchlist that didn’t blow our minds by any stretch of the imagination, but did log some solid intraday increases that warrant continued observation for each of them.

Catalyst Pharmaceuticals, Inc. CPRX
Daily Range: 1.63-2.07 – Max Gain: 27%

Impax Laboratories, Inc. IPXL
Daily Range: 10.50-13.00 – Max Gain: 24%


Extended Watchlist:
BRSE, OWCP, CARA, NVIV, SHIP, SSH, SBLK

Blue Horseshoe Stocks: JNUG Recap & Much More

Direxion Daily Jr Gld Mnrs Bull 3X ETF  (JNUG) – Recap

Despite only providing a fleeting opportunity for gains on Tuesday morning after we submitted our options trading idea for the JNUG chain, we followed up with a reminder in yesterday’s report that the idea was still in play, and that we’d need to keep our heads on a swivel looking out for the move we were hoping for.

With the help of a Fed rate hike of a quarter of a percentage point, announced by Chairperson Janet Yellen yesterday, our specified contracts, the JNUG 03/31 $7-8 Calls took a serious turn for the better.

The daily ranges and potential profits were as follows:

$7 Calls – Range: .40-1.40 – Max Gain: 250%
$7.50 Calls – Range: .35-1.00 – Max Gain: 186%
$8 Calls – Range: .20-.87 – Max Gain: 335%

Once again, we’re going to reiterate our interest in these ideas, which could be in line to extend their highs, with JNUG gapping up in early trading this morning.


Aralez Pharmaceuticals, Inc. ARLZ

We placed ARLZ on bottom watch yesterday morning in what turned out to be a fantastic stroke of good timing. We just wanted to update readers this morning on the reversal which did indeed occur during the session. While the intraday gain potential topped out at 25% as the stock ran from the open (and also low of day) at 2.11 to as much as 2.63.

The inverted hammer candle that the stock posted yesterday is often thought to be an indicator of the end of a downward pattern, so we’ll be very interested to continue tracking ARLZ in sessions to come. Chart indicators are still looking very ripe, and we’d be surprised if the show was over after just a 25% rise.


Cannabis Sector Comments

Lastly, we just want to address the cannabis sector, particularly those stocks that are connected to legal recreational marijuana. After some very damaging comments made recently by the Trump Administration wherein it was suggested that the government could crack down on legal weed, yesterday we witnessed something of a reversal from Jeff Sessions.

Sessions appeared to hint at insufficient DOJ funding as a primary reason that perhaps the current regime will not be changing Obama-era guidance on leaving the treatment of recreational weed as a states’ rights issue.

On the heels of this development, we’re going to want to keep closer tabs on the cannabis sector once again, particularly those plays that lost a lot of ground after the first round of comments from Washington.

Some of our go-to favorites in the space have been OWCP, TRTC, SING, SGDH, CBIS, and MJNA, so we’ll be tracking these more closely in the days and weeks ahead, along with the sector as a whole, as stated above.


Fresh Options Idea:

The TSLA chart is looking ripe for a recovery, and the stock is gapping up moderately in premarket trading this morning. We want to signal a range of calls to monitor in the TSLA chain to potentially take advantage of what could be a protracted recovery. We’re going to zero in on the TSLA 04/07 $270-277.50 Calls, and monitor them in the days and weeks ahead.


Extended Watchlist:
NAK, ZSAN, ORCL, TPLM, PLX, RXII, IDRA

Blue Horseshoe Stocks: Potential Bottom-Plays & More


Potential Rebound Plays

U.S. Stem Cell, Inc. USRM  -We caught USRM for some nice gain opportunities a couple of weeks back. We had initially begun tracking this play after mentioning it on the morning of February 27th. Subsequent to that, we had witnessed an impressive run from a low of .014  to .0545, for a 289% gain in a span of just two sessions.

That was followed by an expected period of consolidation, but it appears as if USRM has found support at .0175. We’re going to want to return to monitoring this play more closely on the chance that it could be gearing up for another run. If it produced a move even a fraction of what we saw before, it will be worth its slot on our watchscreens.

______

Iconic Brands, Inc. ICNB – Speaking of familiar plays that could be in line for a rebound in upcoming sessions, we want to swing back around to ICNB this week. We had tracked this one to some decent gains after tagging it for observation on January 24th. Following that, the stock would trade in a range from .018 up to .0339, a respectable move of 88%

But like the above-mentioned stock, after its run, it basically underwent a big-time consolidation which lasted nearly a whole month. That brings us up to yesterday, when we noticed ICNB giving off something of a rebound signal. We’ll go back to watching more closely in the next few sessions.


Aralez Pharmaceuticals, Inc. ARLZ – Bottom Watcher

ARLZ has been falling off a cliff this week, and despite the fact that it may yet have further to fall, we’re going to want to begin monitoring it as it attempts to sniff out a solid support level. There could definitely be some opportunities waiting for traders that can properly time the recovery.



Direxion Daily Jr Gld Mnrs Bull 3X ETF  (JNUG) – Reminder

Apart from some quick chances for early gains yesterday, our freshly formulated options idea for JNUG may need some time to mature. That’s why we chose an expiration date a couple of weeks out. We’ll continue to have the JNUG 03/31 $7-8 Calls on our radars moving forward.


Extended Watchlist:
DTII, AVXL, AXAS, OWCP, SPCL, IMMU, CVRS

Incoming search terms:

  • usrm stock chat
  • immu stock blog

Blue Horseshoe Stocks: New Highs for OWCP, VDRM & More

OWC Pharmaceutical Research Corp. OWCP – Update

Our readers might have had to do a double-take when we reported our observed range on OWCP leading into yesterday’s session, which was a record-setting 57,956% from the low we saw subsequent to alerting the stock in our premarket report from September 29th (.0036).

We upped the ante even further, stating that “we wouldn’t even be surprised to see our unreal observed range extended even further over coming sessions.”

Sure enough, the stock once again set new highs, trading in a daily range from 2.16 to 3.23 on monstrous volume; good for intraday gains of up to 50% But hold onto your hats, folks, because that new high tabulates to an overall increase of 89,622% in the span of less than four months!

It’s the largest gain of any pick we’ve ever issued, and may hold that record for quite some time, so we just have to give ourselves a huge pat on the back! As to anyone who was along for this ride that had the potential to spawn new millionaires, we salute you as well!


ViaDerma, Inc. VDRM

In terms of alerts that originated in 2017, VDRM is one of our top performers. The stock traded with some excellent price action and volatility yesterday after we included it in our morning report.

There was an early run from .0375 to .065, which works out to an intraday pop of 73% and that was followed by a dip-and-rip from .0376 to a strong close at .0625 (+66%).

Far more impressive is the total amount of ground VDRM has covered since our alert on the stock from January 13th, at which time it was trading at a low of .0048. While it’s peanuts compared to the previously mentioned play, in and of itself, a gain of 1254% in less than six weeks is definitely something special!


Extended Watchlist:
BTX, PPHM, THCT, PURA, KGKG,
CETX(Bottom-Watch)

Incoming search terms:

  • owcp stock forum
  • kadgkgtag

Blue Horseshoe Stocks: The Incredible Run of OWCP & More

OWC Pharmaceutical Research Corp. OWCP

Our primary order of business this morning is to do a nice recap of what is perhaps the most profit-potential-packed pick in the long history of our newsletter’s existence! We’ve had percentage gainers of 5,000, 10,000 with relative regularity- and even the occasional 20,000 percenter- but nothing even approaching the move we’ve witnessed since tagging OWCP as a bottom play this fall, in our premarket report from September 29th.

The climb from the .0036 low we observed that morning would have been difficult to fathom at the time, but over the next four months, it has gone on to impress in a monumental way. Despite slight consolidations along the way, OWCP has persisted through multiple patches of resistance in arriving at yesterday’s new high of 2.10, marking a ridiculous overall run of 57,956%

Considering the fantastic bullish close the stock had yesterday, we wouldn’t even be surprised to see our unreal observed range extended even further over coming sessions.


Wal-Mart Stores, Inc. WMT – Options Update

In yesterday’s premarket report, we updated readers on our WMT options idea from January 31st. We were looking for an extended-term rebound when we signaled the WMT 03/03 $68-$69.50 Calls, and that’s exactly what we’ve gotten.

Leading into yesterday’s session we touted the excellent gain opportunities we had seen to that point in our selected contracts, which ranged from 166-246% We also made it a point to caution that with the way the stock was behaving in the premarket, we expected to see those ranges extended in a significant manner.

As you can see from updated figures below, the overall ranges on our observed plays were more than doubled with yesterday’s activity:

$68 Calls – Range: .86-4.20 – Max Gain: 388%
$68.50 Calls – Range: .57-3.75 – Max Gain: 558%
$69 Calls – Range: .48-3.25 – Max Gain: 577%
$69.50 Calls – Range: .41-2.75 – Max Gain: 570%

______

FRESH OPTIONS IDEA:

Garmin Ltd. GRMN – On the heels of it’s impressive earnings beat, we’re going to tag the GRMN 03/17 $52.50-60 Calls for observation this morning.


Extended Watchlist:
PPHM, OXIHF, VDRM, MJTK, TOL